Blog

Toni Choueiri: Excited for PMC2024 where over 7000 riders are focused on 1 mission

Photo from Toni Choueiri/X

Jul 22, 2024, 13:38

Toni Choueiri: Excited for PMC2024 where over 7000 riders are focused on 1 mission

Toni Choueiri posted on X:

“Last training ride before Pan-Mass Challenge ride on Team More Cowbell! Excited for PMC2024 where over 7000 riders are focused on 1 mission: Curing Cancer with Dana-Farber Cancer Institute! Many riders at our Dana-Farber Lank Center for Genit Center!”

View the information attached to the post.
Source: Toni Choueiri/X

Toni Choueiri is the Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute (DFCI), co-leader of the Kidney Cancer Program at Dana-Farber/Harvard Cancer Center, and the Jerome and Nancy Kohlberg Chair and Professor of Medicine at Harvard Medical School. He is the Medical Director of International Strategic Initiatives at Dana-Farber and past President of the Medical Staff at DFCI (2016-2018).

He received the George Canellos Award for Excellence in Clinical Investigation and Patient Care from DFCI in 2013, the Eugene Schonfeld Award from the Kidney Cancer Association (KCA) in 2016, and is a 2021 Giants of Cancer Care inductee. He serves on the National Comprehensive Cancer Network (NCCN) Kidney Cancer Panel, KidneyCan Board, the National Cancer Institute (NCI) GU Steering Committee, and is past Chairman (2015-2018) of the Medical and Scientific Steering Committee of the KCA.

Dr. Choueiri is an elected member of the American Society of Clinical Investigation (ASCI). In addition, he is an Aresty Scholar from the Wharton School of Business at the University of Pennsylvania.